Calcitriol Market by Product Type (Calcitriol Capsule, Calcitriol Solution, and Others), by Application (Osteoporosis, Renal Osteodystrophy, and Others), and by Distribution Channel (Direct Sales and Distributor): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2024

Global calcitriol market expected to generate revenue of around USD 470 million by 2024, growing at a CAGR of around 4.3% between 2018 and 2024. Valcitriol market driven by the increased prevalence of osteoporosis and other bone-related diseases, increase in renal osteodystrophy, etc.

06-Dec-2018 | Number of pages: 110 | Report Code: ZMR-3601 | Report Format : | Status : Published

Analysis

Calcitriol is an active form of vitamin D, which is found in the human body. It is normally produced in the kidneys through the conversion of 25-hydroxycholecalciferol into 25-hydroxyvitamin D-1 a-hydroxylase. Sometimes, the formation of vitamin D in the body is very low compared to the required quantity, which leads to various health conditions, such as Osteoporosis, renal osteodystrophy, etc. To prevent such conditions, vitamin D is taken externally in the form of Calcitriol drug that regulates the normal functioning of the human body. It maintains the calcium level in the body by increasing the absorption of phosphate and calcium in the gastrointestinal tract. Calcitriol is generally used in the treatment of osteoporosis and hypocalcemia. It does not have any side effects like other medicines, but dry-mouth, vomiting, constipation, headache, minor abnormalities in kidney, abdominal pain, nausea, muscle pain, etc. can be observed in the patients.

There are various factors driving the growth of the calcitriol market, which includes the increased prevalence of osteoporosis and other bone-related diseases, increase in renal osteodystrophy, etc. As per the International Osteoporosis Foundation report, annually, osteoporosis cause more than 8.9 million fractures globally and affects around 75 million people in Europe, the U.S., and Japan. Furthermore, growing healthcare facilities and increasing expenditure related to advanced and developing healthcare facilities are also likely to promote the growth of the calcitriol market over the forecast time period. Moreover, the patent expiry of branded drugs, increase in the use of generics, and growth in the investments related to R&D by major market players are expected to create new opportunities in the calcitriol market over the forecast time period. However, the stringent regulatory process and intellectual property rights might inhibit the growth of the calcitriol market over the forecast time period.

Global Calcitriol Market

Calcitriol market is classified based on product type, application, and distribution channel. On the basis of product type, the calcitriol market is segmented into calcitriol capsule, calcitriol solution, and others. The calcitriol solution segmented is likely to grow rapidly over the forecast time period. On the basis of application, the calcitriol market is categorized into osteoporosis, renal osteodystrophy, and others. Renal osteodystrophy is likely to grow rapidly over the forecast time period. On the basis of the distribution channel, the calcitriol market is segmented into direct sales and distributor. The direct sales channel is expected to dominate the calcitriol market in the future.

North America is expected to dominate the calcitriol market over the forecast time period, due to the presence of advanced healthcare facilities. Europe is likely to closely follow North America in terms of revenue over the estimated timeframe. The Asia Pacific is anticipated to be the fastest growing region in the upcoming years. The Middle East and Africa and Latin America are also expected to experience moderate growth in the near future.

Some of the major players of the calcitriol market include F. Hoffmann-La Roche Ltd., Sun Pharmaceutical Industries Ltd., GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals, Akorn, Incorporated, Strides Pharma Science Limited, and Amneal Pharmaceuticals LLC, among others.


Related Reports

Home Blood Pressure Monitoring Devices Market: by Product (Upper Arm Monitors, Wrist Monitors, and Accessories), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Other Distribution Channels): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 130 | Report Code: ZMR-5131 | Report Format:

According to the report, global demand for home blood pressure monitoring devices market was valued at USD 1,093.1 million in 2018, and is expected to generate revenue of USD 1,611.3 million by end of 2025, growing at a CAGR of 5.7% between 2019 and 2025 The report covers forecast and analysis f...Read More

Orthostatic Hypotension Drugs Market: by Diagnostic Test Type (ECG, Blood Tests, Stress Test and Other), Drug Type (Midodrine, Northera (droxidopa), Fludrocortisone, Caffeine and Others) and End user (Hospitals, ASCs and Clinics and Others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5123 | Report Format:

The report covers forecast and analysis for the Orthostatic Hypotension Drugs market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Orthosta...Read More

Carcinoembryonic Antigen Market: by Application (Thyroid Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Gastrointestinal Cancer and Other Applications); by End User (Research and Academic Institutes, Diagnostic Centers, Hospitals and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5122 | Report Format:

The report covers forecast and analysis for the carcinoembryonic antigen market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the carcinoembryonic antige...Read More

Macular Degeneration Treatment Market: by Drug Class (Anti-VEGFs and Other Drugs); by Indication (Wet Age-related Macular Degeneration (wAMD) and Dry Age-related Macular Degeneration (dAMD)); by Distribution Channel (Ambulatory Surgical Centers, Ophthalmic Clinics and Hospitals): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Nov-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5117 | Report Format:

The report covers forecast and analysis for the macular degeneration treatment market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the macular degenerat...Read More

Plantar Fasciitis Treatment Market: by Type (Medication Therapy [Oral, and Parenteral], Orthotics, Shockwave Therapy [Extracorporeal Shock Wave Therapy, and Intracorporeal Pneumatic Shockwave Therapy], Surgery, and Others), and by End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Nov-2019 | Price : $ 4199.00 | Pages: 130 | Report Code: ZMR-5116 | Report Format:

According to the report, global demand for plantar fasciitis treatment market was valued at USD 603.3 million in 2018, and is expected to generate revenue of USD 2,469.1 million by end of 2025, growing at a CAGR of 22.3% between 2019 and 2025 The report covers forecast and analysis for the globa...Read More

Request Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.